Exhibit 99.1 CENCORA REPORTS FISCAL 2026 FIRST QUARTER RESULTS Revenue of $85.9 billion for the First Quarter, a 5.5% Increase Year-Over-Year First Quarter GAAP Diluted EPS of $2.87 and Adjusted Diluted EPS of $4.08 Adjusted Operating Income Guidance Raised to Growth of 11.5% to 13.5% Adjusted Diluted EPS Guidance Range Reaf irmed at $17.45 to $17.75 for Fiscal 2026 Company Completes Acquisition of OneOncology CONSHOHOCKEN, PA, February 4, 2026 - Cencora, Inc. (NYSE: COR) reported that in its fiscal year 20 ...

Revenue and Sales Performance - Second quarter revenue was $295.9 million, with reported and organic growth flat compared to the prior year[7]. - The Protein Sciences segment reported net sales of $215.1 million, a 2% increase from $211.6 million in the same quarter last year[12]. - The Diagnostics and Spatial Biology segment's net sales were $81.2 million, a decrease of 4% from $84.1 million year-over-year[13]. - Total consolidated net sales for the quarter were $295,877 thousand, slightly down from $297,031 thousand in the previous year, indicating a decrease of 0.4%[27]. - The Protein Sciences segment revenue for the quarter was $215,084 thousand, a slight increase from $211,551 thousand in the previous year, showing a growth of 1.2%[34]. - The Diagnostics and Spatial Biology segment revenue for the quarter was $81,180 thousand, down from $84,135 thousand in the same quarter of 2024, representing a decline of 3.5%[34]. Earnings and Profitability - GAAP earnings per share (EPS) increased to $0.24 from $0.22 year-over-year, while adjusted EPS rose to $0.46 from $0.42[9][10]. - Adjusted operating margin improved to 31.1%, an increase of 100 basis points compared to the prior year period[7]. - GAAP operating income increased 15% to $54.5 million compared to $47.4 million in the same quarter last year[9]. - Adjusted EBITDA for the quarter was $103,415 thousand, compared to $96,111 thousand in the same quarter of 2024, reflecting an increase of 7.4%[27]. - Non-GAAP adjusted net earnings for the quarter were $72,114 thousand, compared to $68,127 thousand in the same quarter of 2024, an increase of 4.4%[32]. - Earnings per share - diluted - Adjusted for the quarter was $0.46, up from $0.42 in the same quarter of 2024, indicating a growth of 9.5%[32]. Tax and Financial Position - The GAAP effective tax rate for the quarter was 25.2%, an increase from 18.6% in the same quarter of 2024[30]. - Total assets as of December 31, 2025, were $2,522,699 thousand, a decrease from $2,557,868 thousand as of June 30, 2025[38]. - Net earnings for the quarter ended December 31, 2025, were $38,009 thousand, an increase from $34,890 thousand in the same quarter of 2024, representing a growth of 6.4%[25]. - Net earnings for the six months ended December 31, 2025, increased to $76,194 million from $68,490 million in 2024, representing a growth of approximately 10.5%[40]. Cash Flow and Investments - Net cash provided by operating activities decreased to $109,996 million from $148,235 million, a decline of about 25.6%[40]. - Cash and cash equivalents at the end of the period were $172,879 million, compared to $177,549 million at the end of the previous period, reflecting a decrease of approximately 2.8%[40]. - The company reported a net cash used in investing activities of $5,316 million, a significant improvement from $26,716 million in the previous period[40]. - Cash dividends paid were $24,914 million, slightly down from $25,424 million, indicating a stable dividend policy[40]. - The effect of exchange rate changes on cash and cash equivalents resulted in a decrease of $797 million, highlighting currency impact on financial results[40]. Strategic Initiatives and Company Outlook - The company generated over $1.2 billion in net sales in fiscal 2025, with approximately 3,100 employees worldwide[14]. - The company celebrates its 50th anniversary in 2026, emphasizing its commitment to innovation and growth[4]. - Ongoing productivity and cost containment initiatives contributed to the improved operating margins across segments[10]. - The company’s non-GAAP financial measures aim to provide greater transparency and facilitate period-to-period comparisons of operational results[41]. - The adjusted operating margin excludes acquisition-related expenses and restructuring costs, which are not reflective of normal operating costs[44]. - The company’s investment in Spear Bio was recorded as a $15,000 million expense in the previous period, indicating strategic investment activities[40].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Commission file number 001-41528 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) Delaware 88-2515116 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 500 W. Monroe Street, Chicago, IL 60661 (Address of princip ...

Exhibit 99 GE HealthCare reports fourth quarter and full year 2025 financial results Company exceeds topline and earnings per share expectations; demonstrates operational resilience Fourth quarter 2025 highlights (1) Full year 2025 highlights (1) Chicago, IL – February 4, 2026 – GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2025. GE HealthCare President and CEO Peter Arduini said, "In our third year as a public company, we've made great ...

1 St. Louis, MO - February 4, 2026 - Bunge Global SA (NYSE: BG) today reported fourth quarter and full-year 2025 results. • Full-year GAAP diluted EPS of $4.93 vs. $7.99 in the prior year; $7.57 vs. $9.19 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences • Q4 GAAP diluted EPS of $0.49 vs. $4.36 in the prior year; $1.99 vs. $2.13 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences • Higher Q4 adjusted EBIT in all segments, driven ...

Asset Management and Investment Portfolio - The company managed approximately $14.6 billion in assets under management through its wholly owned portfolio company, Ivy Hill Asset Management, L.P. (IHAM) as of December 31, 2025[47]. - The investment portfolio primarily consists of first and second lien senior secured loans, subordinated debt, and preferred equity, with debt investments generally ranging between $30 million and $500 million each[39][40]. - The investment portfolio's industrial composition as of December 31, 2025, included 23.8% in Software and Services and 12.4% in Financial Services[55]. - The geographic composition of the portfolio as of December 31, 2025, included 22.9% in the Midwest and 20.3% in the West[57]. - The company monitors 603 portfolio companies, with 14% entitled to board seats or observation rights, representing approximately 24% of the portfolio at fair value[84]. - The company employs an investment rating system that categorizes investments on a scale of 1 to 4, with 1 indicating substantial risk and 4 indicating the least risk[89]. - The company has achieved a realized gross internal rate of return of approximately 13% on exited investments since its IPO, with total proceeds from exited investments amounting to approximately $71.7 billion[59]. Investment Strategy and Risk Management - The company has a rigorous investment selection process that includes extensive due diligence, with approximately 30-40% of initially reviewed investments proceeding to the due diligence phase[67]. - Approximately 10-15% of all investments initially reviewed by the company will be presented to the investment committee for approval[70]. - Only about 3-5% of the investments initially reviewed will result in the issuance of formal commitments and transaction closings[71]. - The company seeks to limit downside potential by requiring financial covenants that enhance credit quality, including leverage and cash flow covenants[77]. - The company has entered into hedging transactions to mitigate interest rate risk, but there is no assurance of their effectiveness[150]. - The company primarily invests in first and second lien senior secured loans, subordinated debt, and preferred equity, with terms generally ranging from three to ten years[72]. - The company may incur significant expenses for evaluating potential strategic acquisition transactions, which could be material to its business[83]. Financial Performance and Debt Management - As of December 31, 2025, the company's asset coverage was 189%, allowing it to borrow up to $2 for every $1 in assets[37]. - As of January 29, 2026, the company had $16.4 billion in total aggregate principal amount of outstanding debt under various debt instruments[124]. - The company had approximately $16.0 billion in aggregate principal amount of indebtedness outstanding as of December 31, 2025[173]. - The weighted average stated interest rate on the company's outstanding indebtedness was 4.9% as of December 31, 2025[169]. - The company must achieve annual returns on total assets of at least 2.5% to cover annual interest payments on its outstanding indebtedness[169]. - The company has completed three debt securitizations through collateralized loan obligations (CLOs) as of December 31, 2025, with total amounts of $476 million, $544 million, and $700 million for ADL CLO 1, ADL CLO 4, and ADL CLO 7 respectively[180]. Regulatory Compliance and RIC Status - The company is regulated as a BDC under the Investment Company Act, adhering to specific regulatory requirements[126]. - The company must distribute at least 90% of its investment company taxable income to maintain its RIC status, limiting available funds for new investments[158]. - Failure to maintain RIC status could result in corporate-level income taxes, adversely affecting net assets and distributions[203]. - The company may face challenges in meeting annual source of income and asset diversification requirements, risking RIC status[203]. - Compliance with RIC requirements may become impractical due to potential changes in relevant provisions of the Code[204]. Market Conditions and Economic Risks - Rising interest rates may increase the cost of debt for portfolio companies, potentially affecting their financial performance and ability to meet obligations[151]. - Inflation has adversely affected the business and financial condition of portfolio companies, increasing costs and impacting consumer spending[152]. - Economic downturns could impair portfolio companies' ability to repay loans, leading to increased non-performing assets and decreased portfolio value[240]. - Legislative actions related to taxes and changes in U.S. tax laws could negatively impact the company and its portfolio companies, affecting long-term financial outcomes[227]. - Changes in U.S. tariff and import/export regulations may harm portfolio companies, potentially leading to reduced access to suppliers or customers and negatively impacting financial results[229]. Strategic Opportunities and Challenges - The company is evaluating potential strategic acquisition opportunities, including other finance companies and asset managers, although no discussions have progressed to a probable completion[83]. - The company may seek to retire or repurchase its common stock and outstanding debt, depending on market conditions and liquidity requirements[125]. - The company faces competitive pressures from various entities, including BDCs, public and private funds, and commercial banks, which may adversely affect its business[183]. - The company competes based on its investment platform, experienced professionals, and focus on middle-market companies rather than interest rates[184]. - The company may lose investment opportunities if it does not match competitors' pricing, which could limit growth and decrease earnings[184]. ESG and Regulatory Scrutiny - The company is subject to increasing scrutiny regarding ESG matters, which may impose additional costs and risks, potentially affecting investor decisions[212]. - Compliance with new ESG regulations, such as the Corporate Sustainability Reporting Directive, could increase management burdens and costs for the company and its portfolio[217]. - Climate change poses significant risks to the company's operations and those of its portfolio companies, potentially leading to increased costs, including insurance[219]. - The company and its portfolio companies are subject to increasing regulatory scrutiny, particularly regarding non-bank lending, which could adversely affect operations and financial condition[225]. Operational Risks - The company relies on key personnel from Ares for future success, and their departure could materially affect operations[154]. - The company is highly dependent on the information systems of Ares Management, and operational risks, including system failures, could disrupt business and affect stock price[234]. - The company faces potential litigation and regulatory investigations, which could be time-consuming and costly, impacting its operations and financial condition[220]. - Increased negative publicity surrounding the private credit industry could harm the company's reputation and affect fundraising efforts[223].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Date: February 4, 2026 UBS Group AG (Registrant's Name) Bahnhofstrasse 45, 8001 Zurich, Switzerland (Address of principal executive office) Commission File Number: 1-36764 UBS AG (Registrant's Name) Bahnhofstrasse 45, 8001 Zurich, Switzerland Aeschenvorstadt 1, 4051 Basel, Switzerland (Address of princi ...

Oaktree Specialty Lending Corporation Announces First Fiscal Quarter 2026 Financial Results Exhibit 99.1 LOS ANGELES, CA, February 4, 2026 - Oaktree Specialty Lending Corporation (NASDAQ: OCSL) ("Oaktree Specialty Lending" or the "Company"), a specialty finance company, today announced its financial results for the first quarter ended December 31, 2025. Financial Highlights for the Quarter Ended December 31, 2025 "We delivered solid results in the first fiscal quarter of 2026 including adjusted net investme ...

Financial Performance - Net sales for Q4 2025 were $3,684.6 million, a decrease of 1.0% from $3,720.5 million in Q4 2024[2] - Net earnings from continuing operations for Q4 2025 were $158.2 million, down from $194.9 million in Q4 2024, resulting in diluted earnings per share of $1.04[2] - Year-to-date 2025, net earnings from continuing operations reached $401.9 million, with diluted earnings per share of $2.65, up from $286.3 million and $1.89 in year-to-date 2024[10] - In Q4 2025, the company reported a gross profit of $5.9 million, compared to $16.1 million in Q4 2024, reflecting a significant decline[18] Profitability Metrics - Gross profit margin improved to 33.2% in Q4 2025 from 30.8% in Q4 2024, reflecting better cost management[2] - In Q4 2025, the gross profit was $1,221.9 million, representing 33.2% of net sales, compared to $1,144.1 million and 30.8% in Q4 2024[9] - The Tools & Outdoor segment reported a profit of $418.3 million in Q4 2025, with a segment profit margin of 13.2%, compared to $298.1 million and 9.2% in Q4 2024[11] - The Engineered Fastening segment reported a profit of $63.2 million in Q4 2025, maintaining a margin of 12.1%, consistent with Q4 2024[11] Cash Flow and Liquidity - Free cash flow for Q4 2025 was $882.9 million, compared to $564.6 million in Q4 2024, indicating improved liquidity[6] - Selling, general and administrative expenses for Q4 2025 were $801.8 million, or 21.8% of net sales, down from $855.2 million and 23.0% in Q4 2024[9] Segment Performance - Tools & Outdoor segment net sales were $3,160.4 million in Q4 2025, down from $3,227.6 million in Q4 2024, while segment profit increased to $418.3 million[8] - Engineered Fastening segment net sales increased to $524.2 million in Q4 2025 from $492.9 million in Q4 2024, with segment profit rising to $63.2 million[8] - Year-to-date 2025, the Tools & Outdoor segment profit was $1,328.8 million, with a margin of 10.1%, compared to $1,197.4 million and 9.0% in year-to-date 2024[13] - The Engineered Fastening segment showed a positive growth of 6% in Q4 2025, contrasting with declines in other segments[19] Asset and Debt Management - Total assets decreased to $21,243.7 million as of January 3, 2026, from $21,848.9 million as of December 28, 2024[4] - Long-term debt decreased to $4,703.3 million as of January 3, 2026, down from $5,602.6 million as of December 28, 2024[4] Shareholder Returns - Dividends per share increased to $0.83 in Q4 2025 from $0.82 in Q4 2024, reflecting a commitment to return value to shareholders[2] Non-GAAP Measures - Adjusted EBITDA for Q4 2025 was $497.3 million, representing 13.5% of net sales, compared to $378.3 million and 10.2% in Q4 2024[16] - The company reported a non-GAAP adjusted EBITDA of $64.1 million in Q4 2025, up from $49.3 million in Q4 2024[20] - Non-GAAP organic revenue growth for the company was -3% in Q4 2025, with a notable decline of -5% in North America[19] - Non-GAAP adjustments for year-to-date 2025 included $396.2 million before income taxes, compared to $466.0 million in year-to-date 2024[16] Strategic Initiatives - The company announced a definitive agreement to sell its Consolidated Aerospace Manufacturing business, with related assets classified as held for sale[8] - The company implemented a voluntary retirement program in June 2025, resulting in costs of $11.5 million year-to-date[20] - The company incurred supply chain transformation costs of $2.4 million in Q4 2025, with year-to-date costs totaling $19.0 million, down from $66.3 million in 2024[18] - The company achieved a gain of $8.1 million from the sale of a distribution center as part of its supply chain transformation efforts[20] Environmental and Impairment Charges - Environmental charges in 2024 were recorded at $143.2 million, primarily due to regulatory changes affecting the Centredale Superfund site[20] - Asset impairment charges in 2025 totaled $20.4 million, with significant impacts from brand prioritization strategy updates[20]

Exhibit 99.1 ARES CAPITAL CORPORATION ANNOUNCES DECEMBER 31, 2025 FINANCIAL RESULTS AND DECLARES FIRST QUARTER 2026 DIVIDEND OF $0.48 PER SHARE DIVIDEND DECLARATIONS New York, NY — February 4, 2026 — Ares Capital Corporation ("Ares Capital") (NASDAQ: ARCC) announced that its Board of Directors has declared a first quarter 2026 dividend of $0.48 per share. The first quarter 2026 dividend is payable on March 31, 2026 to stockholders of record as of March 13, 2026. DECEMBER 31, 2025 FINANCIAL RESULTS Ares Capi ...